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The systemic inflammatory response syndrome,
organ failure, and mortality after abdominal aortic
aneurysm repair
M. J. Bown, MB, BCh, MRCS, M. L. Nicholson, MD, FRCS, P. R. F. Bell, MD, FRCS, and
R. D. Sayers, MD, FRCS, Leicester, United Kingdom
Background: Organ failure is a major cause of morbidity and mortality after abdominal aortic aneurysm (AAA) repair.
The aim of this study was to determine the relationships between the systemic inflammatory response syndrome (SIRS),
organ failure, and mortality after AAA repair and to determine whether the clinical monitoring of SIRS was a useful
adjunct to clinical method.
Methods: One hundred consecutive patients undergoing open AAA repair were prospectively studied. Patients were
divided into three groups: those undergoing elective AAA repair, those with symptomatic but nonruptured AAA, and
those with ruptured AAA. The presence of SIRS and organ failure was recorded on a daily basis for each patient until
discharge or death.
Results: Most patients had SIRS develop during the postoperative period: 89% of the elective group, 92% of the emergency
nonruptured (urgent) group, and 100% of the ruptured group. Multiorgan failure occurred in 3.8% of the elective group,
38% of the urgent group, and 64% of the ruptured AAA group. After ruptured AAA repair, the concurrent absence of
both SIRS and any organ failure for 48 hours had a sensitivity of 93% and a specificity of 91% as a predictive indicator of
subsequent survival to hospital discharge. Patients in whom multiorgan failure developed after ruptured AAA repair had
a significantly higher mortality rate (69%) than those who did not (0%; P  .001; 95% CI for the difference, 30.2% to
85.8%).
Conclusion: The differences in the incidence rate of multiorgan failure between the patient groups compared with the high
incidence rate of SIRS in all patient groups supports the two-hit hypothesis of multiorgan failure. The presence of
multiorgan failure after ruptured AAA repair is associated with poor outcome. The absence of SIRS and organ failure in
these patients is a good predictive indictor of survival. (J Vasc Surg 2003;37:600-6.)
Organ failure, either single or multiple, is responsible
for a large proportion of the morbidity and mortality asso-
ciated with abdominal aortic aneurysm (AAA) repair.1
Postoperative management of patients after AAA repair
involves intensive monitoring of organ function and ag-
gressive therapeutic intervention if organ dysfunction or
failure occurs. Unfortunately, a significant number of pa-
tients in whom organ failure develops may not survive,2 and
those who do survive usually have prolonged stays on
critical care wards at considerable financial and human cost.
Early detection and treatment of organ dysfunction
may prevent progression to single/multiple organ failure
and death.3 However, patients recovering from AAA repair
have varying degrees of altered physiologic, hematologic,
and biochemical homeostasis, and the identification of
organ dysfunction in these patients is not straightforward.
The systemic inflammatory response syndrome (SIRS)
is an initial response to injury and reflects activation of
inflammatory cascades4 with production of systemic in-
flammatory mediators. SIRS should precede the develop-
ment of organ failure and therefore may be a useful indica-
tor of impending organ dysfunction. The measurement of
inflammatory markers associated with SIRS has been pro-
posed as a method of identification of those at risk of
multiple organ failure5; however, determination of whether
a patient has SIRS or not is considerably easier than the
measurement of inflammatory mediators. SIRS is defined
by the concurrent presence of two or more of four simple
clinical criteria (Table I).3 SIRS can be rapidly assessed at
the bedside without the need for any special equipment or
expertise other than sound clinical method. The aim of this
study was to determine the incidence rate of SIRS after
AAA repair and its temporal relationships with organ failure
and mortality in these patients to identify whether the
routine monitoring of SIRS may be useful in these patients.
PATIENTS AND METHODS
A prospective study was performed of 100 consecutive
patients undergoing conventional (open) AAA repair who
survived the initial operation. Patients were classified into
three groups: those undergoing elective repair (elective),
those undergoing emergency surgery for symptomatic but
nonruptured aneurysms (urgent), and those with ruptured
aneurysms (ruptured). Urgent AAA repairs were those with
patients admitted with symptomatic AAA in whom surgery
was performed as an emergency without full preoperative
work-up because they were perceived to be at risk of
imminent rupture or thought to have actually had rupture
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but subsequently were found not to have ruptured at
laparotomy. Aneurysm rupture was defined as the presence
of free intraperitoneal blood or retroperitoneal hematoma
at laparotomy. All patients with ruptured AAA irrespective
of the degree of preoperative cardiovascular collapse were
included in the same outcome group. Procedures per-
formed via both the transperitoneal and the retroperitoneal
approaches were included as were those patients with su-
prarenal aneurysms. The study was approved by the local
ethics committee.
For each patient, the presence of SIRS and organ failure
in the previous 24 hours was recorded on a daily basis from
the first postoperative day until hospital discharge or death.
Failure in the following organ systems (according to the
definitions of Knaus et al6) was recorded: cardiovascular,
respiratory, renal, hematologic, and neurologic (Table II).
Any organ failure was defined as one or more organ systems
failing during a single 24-hour period, and multiorgan
failure was defined as the presence of two or more organ
system failures during the same 24-hour period. When any
of the criteria defining SIRS or organ failure had not been,
or could not be, measured by the surgical or critical care
teams, they were assumed to be within normal limits. The
assumption of normality for these criteria was to enable the
application of SIRS criteria to those clinical data that are
routinely recorded without having to make additional clin-
ical or laboratory assessments. Mortality was defined as
death before hospital discharge.
Sedated, ventilated patients were assumed to have the
same Glasgow Coma Scale score as they had when ventila-
tion was initiated. Patients with chronic organ impairment
(with the exception of dialysis-dependant chronic renal
failure) were assessed with the same criteria for organ failure
as all other patients.
RESULTS
Patient demographics. One-hundred patients were
included in the study (80 male; 80%), with a overall median
age of 72 years (range, 48 to 85 years). Sixty-two patients
underwent elective aneurysm repair (46 male; 74%), with a
median age of 72 years (range, 48 to 85 years); 13 patients
underwent urgent repair (12 male; 92%), with a median age
of 74 years (range, 62 to 82 years); and 25 patients under-
went emergency repair of ruptured AAA (22 male; 88%),
with a median age of 72 years (range, 59 to 80 years).
Mortality. Overall, 15 patients (15%) died. The mor-
tality rate was 4.8% in the elective group, 7.7% in the urgent
group, and 44.0% in the ruptured aneurysm group. For the
entire 100 patients in the study, the mortality rate was
significantly higher in those patients with any organ failure
(23%) compared with those without (0%; P  .008, Fisher
exact test; 95% CI for the difference, 11.8 to 36.7) and in
those in whom multiorgan failure developed (50%) com-
pared with those in whom it did not (3.9%; P .0001; 95%
CI for the difference, 26.2 to 64.8; Table III).
Elective AAA repair Sixty-two patients underwent
elective AAA repair. SIRS developed in 55 patients (89%)
during the postoperative period, failure of one or more
organ systems developed in 29 patients (47%), multiorgan
failure developed in three patients (4.8%), and three pa-
tients (4.8%) died (one from myocardial infarction, one
from perforated ischemic colitis, and one from a mesenteric
infarction).
Of the 29 patients in whom any organ failure devel-
oped, 28 also had SIRS develop. Seven patients had SIRS
develop before organ failure, 13 concurrently with organ
failure, and eight after organ failure. In total, 20 patients
(68.9%) had SIRS develop either before or concurrently
with any organ failure compared with nine patients (31.0%)
in whom SIRS developed either after organ failure or not at
all. Although SIRS was relatively common in the early
postoperative period, it rapidly decreased over time in these
patients, and organ failure also followed a similar pattern
(Fig 1).
Urgent AAA repair. Only 13 patients had urgent
repair of symptomatic but nonruptured AAA. Twelve pa-
tients (92%) had SIRS develop, seven patients (54%) had
failure of one or more organ systems develop, five patients
(38%) had multiorgan failure develop, and one patient (8%)
died of multiorgan failure.
In the urgent group of those patients in whom any
organ failure developed (seven patients; 54.0%), six had
SIRS develop before or concurrently with organ failure
(85.7%) and one after organ failure. Five patients in the
urgent group had multiorgan failure develop. One of these
patients had SIRS develop before multiorgan failure, and
four concurrently with multiorgan failure. No patient
had multiorgan failure develop after urgent AAA repair
without SIRS either preceding it or occurring at the same
time.
Ruptured AAA. Twenty-five patients had ruptured
AAA. All patients in this group had SIRS develop, and all
patients had one or more organ failures develop. Sixteen
patients (64%) had multiorgan failure develop, and 11
patients died (44%).
In these 25 patients, SIRS preceded any organ failure in
six and occurred concurrently with any organ failure in 15.
Sixteen patients had multiorgan failure develop, 10 of
whom had SIRS develop before multiorgan failure, and the
remaining six had SIRS develop concurrently with multi-
organ failure. SIRS, therefore, occurred concurrently or
before organ failure in 84% of those patients in whom organ
failure developed and in 100% of patients in whom multi-
organ failure developed. In contrast to the elective aneu-
Table I. SIRS criteria
Two or more of following:
Temperature 38° C or 36° C
Heart rate 90 bpm
Respiratory rate 20 breaths/min or PaCO2 4.3 kPa (32.25
mm Hg)
WBC 12 000 cells/mm3 or 4000 cells/mm3 or 10%
immature (band) forms
WBC, White blood cells.
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rysm group (Fig 1)—although again, SIRS was relatively
common in the early postoperative period in the ruptured
aneurysm group—it persisted rather than resolved rapidly
(Fig 2), as did any organ failure and multiorgan failure.
Multiorgan failure was either the cause of or a signifi-
cant factor in most deaths after ruptured aneurysm repair
(10 of 11 deaths; 91%; the other death from a cerebral
infarction). Those patients in whom multiorgan failure
developed had a significantly higher mortality rate (69%)
than those in whom it did not (0%; P  .001; 95% CI for
the difference, 30.2 to 85.8; Table III).
The mortality rate in the 20 patients in whom cardio-
vascular failure developed was 55.0% (11 patients), com-
pared with 0.0% (0 of five patients) in those in whom it did
not (P  .05, Fisher exact test). In those patients in whom
renal failure developed (16 patients), the mortality rate was
62.5% (10 patients), compared with 11.1% (one of nine
patients) in those in whom it did not (P .03, Fisher exact
test). No significant difference was seen in mortality rate
between those patients with and without development of
respiratory, hematologic, or neurologic failure (P  1.0,
.44, and .44, respectively).
In this group, 12 patients had recurrent multiorgan
failure develop after resolution of the initial episode. Of
these 12 patients, 10 did not undergo resolution of SIRS
before development of recurrent multiorgan failure. Two
patients had multiorgan failure develop despite previous
SIRS negativity for 24 hours. One of these patients had
SIRS develop 2 days before development of recurrent mul-
tiorgan failure, but the other had SIRS develop on the same
day as multiorgan failure. In this group, the absence of
SIRS and the absence of SIRS or any organ failure for 24,
48, and 72 hours in relation to subsequent mortality was
examined.
Seven patients with ruptured AAA died despite SIRS
having resolved for at least 24 hours. This number de-
creased after 48 and 72 hours of resolution of SIRS to six
and four, respectively. Only two patients died after SIRS
and organ failure had resolved for 24 hours, and this
decreased to one patient (who died of a cerebrovascular
Table II. Definitions of organ failure according to Knaus et al6
Organ system Criteria for failure
Cardiovascular Heart rate  54 bpm
Mean arterial pressure  49 mm Hg
Ventricular tachycardia or ventricular fibrillation
pH  7.24 and PaCO2  49 mm Hg (6.57 kPa)
Respiratory Respiratory rate  5 breaths/min or  49 breaths/min
PaCO2  50 mm Hg (6.58 kPa)
AaDO2  46.5
Dependant on ventilator on 4th organ failure day (ie, not applicable until
after 72 h organ failure)
Renal (unless on chronic dialysis before admission) Urine output  480 mL/24 h or  160 mL/8 h
Serum urea  16.6 mmol/L
Serum creatinine  308 mol/L
Hematologic Leucocyte count  1  103/mm3
Platelet count  20  103/mm3
Hematocrit  20%
Neurologic Glasgow coma scale  6 (in absence of any sedation at any one point in day)
One or more positive variables in each category during 24-hour period constitutes that organ failing on that day.
AaDO2, Alveolar-arterial oxygen difference.
Table III. Mortality rates for patients with and without SIRS, organ failure, and multiorgan failure values are
percentages. Note: all patients with ruptured AAA had SIRS and organ failure develop.
SIRS Organ failure Multiorgan failure
Yes No
Difference
(95% CI) P value* Yes No
Difference
(95% CI) P value* Yes No
Difference
(95% CI) P value*
All patients 16.3 0.0 16.3 .602 23.0 2.0 21.0 .008 50.0 3.9 46.1 .0001
(n  100) (16.7 to 25.2) (8.6 to 33.0) (26.2 to 64.8)
Elective 5.5 0.0 5.5 1.00 6.9 3.0 3.9 .595 0.0 3.1 -3.1 1.000
(n  62) (30.2 to 14.9) (9.4 to 19.1) (8.7 to 53.1)
Urgent 8.3 0.0 8.3 1.00 14.3 0.0 14.3 1.000 20.0 0.0 20.0 .385
(n  13) (71.3 to 35.4) (26.5 to 51.3) (16.3 to 62.4)
Ruptured       68.8 0.0 68.8 .001
(n  25) (30.2 to 85.8)
*Fisher exact test.
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accident) if the “absence time” was increased to 48 and 72
hours. The resolution of SIRS and the resolution of both
SIRS and organ failure were examined as predictive tests for
survival after ruptured aneurysm repair. The sensitivity,
specificity, positive predictive value, negative predictive
value, and likelihood ratio for each test criteria are shown in
Table IV. In isolation, the resolution of SIRS is a sensitive
test for prediction of survival after ruptured AAA repair but
has low specificity. If the resolution of any organ failure is
included in the test criteria, the specificity of the test
increases substantially, with only a slight reduction in sen-
sitivity.
Variation between patient groups Fig 3 shows the
incidence rates of SIRS, any organ failure, and multiorgan
failure in the three patient groups (elective, urgent, and
ruptured). Although SIRS was common in all patients, its
prevalence varied with time in each group (Fig 4). In the
elective and urgent groups, the prevalence of SIRS rapidly
declined in the early postoperative period and remained
low, but in the ruptured aneurysm group, the presence of
SIRS persisted in a significant number of patients over a
prolonged period.
The median time to the onset of both SIRS and any
organ failure was 1 day for all groups of patients. In the
elective and ruptured groups, the median time to onset of
multiorgan failure was 3 days, and in the urgent group, it
was 1 day. The median times to onset of SIRS (1 day), any
organ failure (1 day), and multiorgan failure (3 days) were
significantly different in the ruptured aneurysm group (P
.007, Kruskal-Wallis test).
Cardiovascular failure was the most common organ
failure overall, occurring in 50% of patients; respiratory
failure occurred in 34%, and renal failure in 24%. Neuro-
logic failure and hematologic failure were relatively uncom-
mon, occurring in 2% and 1% of patients, respectively. The
relative incidence rates of cardiovascular, respiratory, and
renal failure were different in the three groups of patients
(Table V). Cardiovascular and respiratory failure occurred
with similar rates in both the ruptured and urgent groups,
and in the elective group, cardiovascular failure was three
times as common as respiratory failure. Renal failure was far
more common in the ruptured group than either the ur-
gent or elective groups.
DISCUSSION
This prospective study shows that SIRS and organ
failure are common after aneurysm repair, particularly after
surgery for rupture. In all patients, the development of
multiorgan failure, and in the ruptured AAA group, the
development of either cardiovascular or renal failure, were
significantly associated with mortality. SIRS occurs concur-
rently with or before any organ failure in most cases, and
also, the resolution of both SIRS and organ failure at any
point during the postoperative period is a useful prognos-
ticator of a successful outcome after ruptured aneurysm
repair.
The difference in the incidence rates of any organ
failure and multiorgan failure between the groups of pa-
tients is marked, but the incidence rate of SIRS in each
group is similar. Because, by definition, SIRS should pre-
cede the development of organ failure, it may be expected
that most patients would have organ failure develop, but
this is not the case, and a similar finding has been shown in
patients in the general intensive care unit.7 The most obvi-
ous clinical difference between these groups is the nature of
the insults that each receives. All patients are subjected to
the surgical trauma of an AAA repair. In the urgent group,
the patients are unselected and frequently not afforded the
same degree of preoperative preparation as the elective
group. The ruptured group also has a varying degree of
hemorrhagic shock before surgery. Given the marked dif-
ferences between the ruptured group and all other patients,
it would appear to be the dual insult of hemorrhagic shock
together with surgery that is responsible for the higher
incidence rate of organ failure, a theory that is supported by
experimental studies.8
One of the limitations of this study is the relatively small
number of patients in the ruptured AAA group. Unfortu-
nately, this group was the only group with a significant
incidence rate of multiorgan failure. It would have been
desirable to examine the temporal changes in the degree
and type of organ failure in those in whom multiorgan
Fig 1. Number of patients with SIRS, any organ failure, and
multiorgan failure in elective aneurysm group during first 15
postoperative days.
Fig 2. Number of patients with SIRS, any organ failure, and
multiorgan failure in ruptured aneurysm group during first 25
postoperative days.
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failure developed, but because of the low numbers of
patients in this group, inferences from any analysis per-
formed on this subgroup would be flawed. Therefore, these
results have not been analyzed in this manner.
Theories regarding the pathogenesis of organ failure in
response to inflammatory insults concentrate around the
host response to the initial insults and the magnitude,
number, and timing of these insults.9 An inflammatory
Fig 3. Incidence rates of SIRS, any organ failure, and multiorgan failure in elective, urgent, and ruptured aneurysm
groups.
Fig 4. Incidence rate of SIRS by patient category over time (first 25 days after surgery).
Table IV. Resolution of SIRS compared with resolution of SIRS and organ failure for three time periods as predictive
tests of survival after ruptured AAA repair
Test criteria
SIRS resolved for SIRS and organ failure resolved for
24 h 48 h 72 h 24 h 48 h 72 h
Sensitivity (95% CI) 100% 100% 100% 81.8% 90.9% 90.9%
(74.1 to 100) (74.1 to 100) (74.1 to 100) (52.3 to 94.9) (62.3 to 98.4) (62.3 to 98.4)
Specificity (95% CI) 35.7% 42.9% 64.3% 71.4% 92.9% 92.9%
(16.3 to 61.2) (21.4 to 67.4) (38.8 to 83.7) (45.4 to 88.3) (68.5 to 98.7) (68.5 to 98.7)
PPV (95% CI) 0.55 0.58 0.69 0.69 0.91 0.91
(0.34 to 0.74) (0.36 to 0.77) (0.44 to 0.86) (0.42 to 0.87) (0.62 to 0.98) (0.62 to 0.98)
NPV (95% CI) 1.0 1.0 1.0 0.83 0.93 0.93
(0.57 to 1.0) (0.61 to 1.0) (0.70 to 1.0) (0.55 to 0.95) (0.69 to 0.99) (0.69 to 0.99)
PPV, Positive predictive value; NPV, negative predictive value.
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response is essential for the continued survival of a patient.
Organ dysfunction and failure in response to injury are, in
part, the result of the excessive activation of inflammatory
pathways, and antiinflammatory mechanisms exist to min-
imize this inflammation. Bone10 describes this as the con-
cept of a compensatory antiinflammatory response syn-
drome (CARS). If SIRS and CARS are in balance, the
inflammatory process is stopped, but if SIRS predominates,
proinflammatory pathways become excessively activated.
The host response (CARS) is largely constant, but the
initial proinflammatory response may vary. If an initial
insult causing SIRS is limited by CARS, homeostasis is
maintained. However, this initial insult may cause priming
of inflammatory pathways, such that a second later insult
causes a degree of inflammation greater than that which
would be expected if the second insult were to occur in
isolation. This is referred to as the two-hit phenomenon.
This second hit is said to occur some days after the initial
insult, and if this were the case, this theory would fail to
explain the differences seen between the groups in this
study. However, more recently, the timing required of a
second hit to cause excessive inflammation has been shown
not to be limited to late in the inflammatory history but also
to occur in the first few hours,11 which is supported by the
data presented previously—the initial insult being the hem-
orrhage associated with aneurysm rupture and the second
being the ischemia-reperfusion injury as a result of aortic
aneurysm repair.
At first,4 SIRS was defined as part of a continuing
inflammatory response that could have progressed from
SIRS to sepsis if microbiologically proven infection oc-
curred and on to severe sepsis if systemic hypoperfusion
occurred. Although these subclassifications may have had a
better predictive ability than SIRS alone, the subjectivity in
their definition adds complexity to SIRS, which alone is an
objective and simply defined phenomenon.
A potential confounding factor in interpretation of the
results of this study is the effects of the operation itself.
SIRS cannot be considered pathognomonic for inflamma-
tion. A normal physiologic response to hypovolemia is
tachycardia and tachypnea, the presence of which alone
would categorize a patient as having SIRS, and in addition,
patients undergoing AAA repair are often hypothermic at
the end of the procedure, a further positive SIRS criteria.
The high incidence rate of SIRS in the immediate postop-
erative period may reflect this, and when originally defined,
the qualification that SIRS “should represent an acute
alteration from baseline in the absence of other known
causes”3 was placed on its definition. It may be that the
persistence of SIRS over time is a more accurate indication
of an inflammatory pathologic process.12 This is supported
by the previous data. The elective group has a high inci-
dence rate of SIRS, but as shown in Fig 3, this is largely
during the early postoperative period. In the ruptured
group, SIRS persists over a longer time (Fig 4). This would
also help to explain the difference in the proportions of each
group with SIRS compared with the proportion with mul-
tiorgan failure. Because SIRS in the ruptured group is more
persistent and more likely to progress to multiorgan failure,
it may more accurately reflect inflammation, whereas in the
elective group many of the patients with SIRS are probably
showing a normal physiologic reaction to surgery.
The assessment of SIRS in this study was performed
with only those clinical and laboratory data that would have
been routinely collected in these patients if they were not
included in this study. This was an attempt to examine how
SIRS would perform in a “normal” clinical setting, where
frequently some of the criteria that define SIRS may not be
available. In this study, these missing data were assumed to
be within normal limits. Although this may not have been
true in all circumstances, this is the situation that occurs in
clinical practice, and because the aim of this study was to
determine how SIRS could be applied to routine clinical
practice, it was believed that this was the most appropriate
solution.
Some patients may have been defined as having organ
failure when this was the result of normal physiologic
responses to surgery. Cardiovascular failure was responsible
for a greater proportion of the total organ failures seen in
the elective group than in the urgent and ruptured groups
(Table III). The criteria for definition of cardiovascular
failure include normocapnic acidosis, severe bradycardia,
and hypotension, all of which may transiently occur as part
of the physiologic response to AAA repair and not be
directly the result of cardiac dysfunction per se. Possible
strategies to prevent the false diagnosis of this and other
organ failures would have been to use one of the other
published systems for defining organ failure, for example,
those described by Goris et al13, Tran et al,14 or Meesters et
al.15 The system defined by Knaus et al6 has considerable
advantages over the other systems. It is based on a sample of
more than 5600 patients; the next largest sample is that of
Tran et al,14 with 497 patients. The system of Knaus et al6
is also specifically designed to be used in critically ill patients
and applied to each 24-hour period of admission to critical
care independently. It also assumes that therapies directed
towards correction of physiologic derangement are in
progress at the time of assessment whereas all of the other
systems use these therapeutic interventions as part of their
criteria for defining organ failure. All of the systems, other
than that of Knaus et al,6 also use subjective criteria in some
of their definitions or physiologic measurements that are
not routinely recorded or measured in the critical care units
Table V. Incidence rate of organ failure after AAA repair
in three groups of patients
Elective
(n  62)
Urgent
(n  13)
Ruptured
(n  25)
Cardiovascular 24 (38.7%) 6 (46.2%) 20 (80%)
Respiratory 8 (12.9%) 5 (38.5%) 21 (84%)
Renal 5 (8.1%) 3 (23.1%) 16 (64%)
Neurologic 0 (0) 1 (7.7%) 1 (4%)
Hematologic 0 (0) 0 (0) 1 (4%)
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where the project took place. Each of these systems has
merits and disadvantages compared with the system used in
this study, and although there may be inaccuracies in
absolute numbers seen, the same system has been used for
all patients, and therefore, the trends shown are likely to be
representative.
The presence of SIRS in a patient after AAA repair is a
useful clinical indicator of potential later multiorgan failure,
particularly after ruptured AAA repair; however, it is limited
by a lack of specificity. It may be possible to increase the
specificity of SIRS with analysis of the total number of
positive SIRS criteria as a predictive test for organ failure
(generating a total SIRS score from 0 to 4). Alternative
methods to SIRS, such as APACHE II16 or SAPS II17
scoring, may be better predictors of organ failure, but these
lack the simplicity of SIRS.
Where use of SIRS as a dichotomous measure does
appear to be of use is in identification of those patients who
are at very low risk of later organ failure and death by its
resolution or absence. The relative simplicity in determina-
tion of whether a patient has SIRS or not is one of its key
features; it adds very little time to the daily review of a
patient on ward rounds. Although many would argue that
the SIRS criteria are usually assessed, albeit subconsciously,
by any clinician reviewing a patient and that further classi-
fication of routine observations is unnecessarily complicat-
ing clinical method, we believe that SIRS is a useful method
of identifying patients in whom the significance of multiple
minor physiologic derangements may be underestimated.
We thank Mr M. J. S. Dennis, Professor NLM London,
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